Sigut

Automated DNA chemical synthesis

December 6, 2021
Automated DNA chemical synthesis

Over the last few decades, several approaches have been developed to synthesise short DNA sequences.

Relevant approaches include the phosphodiester method and the H-phosphonate method. However, higher yields and higher product quality and better efficiency and shorter synthetic times can be achieved using the solid-phase synthesis of oligonucleotides that employs nucleotide-3’-O-phosphoramidites as monomers.

In this approach, the whole synthesis is conducted on solid support. Automated machines (called DNA synthesizers) have been developed to efficiently and quickly perform the synthesis. Building blocks for this synthesis are nucleotide-3’-O-cyanoethylphosphoramidites (CEP).

Generally, the 5’-hydroxyl group is protected with a dimethoxytrityl (DMT) group, while amino groups on nucleobases are protected with a benzoyl group (for adenosine and cytidine) or isobutyryl group (for guanosine).

Figure 1. Most employed building blocks in the automated DNA chemical synthesis.

 

Mechanism

At the beginning of the synthesis, the first nucleotide is attached to the solid support, loaded into a small column. The DNA synthesiser automatically carries on all the synthesis steps (shown in Scheme 1) by delivering necessary reagents and reactants to the column in which the oligonucleotide product is synthesised—the synthesis proceeds in the 3’ to 5’ direction (opposite to enzymatic synthesis). Finally, desired products are generally purified by standard desalting spin-columns or HPLC.

The main advantage of the solid-phase synthesis over traditional enzymatic synthetic approaches consists of a much larger possible scale. DNA oligonucleotides can be prepared up to μmols scale against the nmol scale of the enzymatic methods.

However, obtaining long DNA sequences via solid-phase synthesis is very difficult, and most reactive chemical groups have to be adequately protected.

Scheme 1. General scheme of the solid-phase synthesis of ONs conducted by an automated DNA synthesiser.

Due to the vast and still quickly growing applications of non-natural oligonucleotides, the design and synthesis of non-natural building blocks for DNA synthesis is gaining outstanding importance.

If a non-natural nucleoside needs to be incorporated via solid-phase synthesis into the product sequence, its relative phosphoramidite has to be prepared and employed, where all other eventual reactive groups must be adequately protected. Also, acyclic or non-nucleoside phosphoramidites can be employed to insert a spacer within the product sequence or insert a modification at one end of the oligonucleotide.

@SantiagoLab, we can offer the design and synthesis of building blocks suitable for inserting a wide range of DNA modifications for different applications into your oligonucleotide products. If you would like to know more, or we can help you with your research, write an email to Krystof Sigut on krystof.sigut@santiago-lab.com or reach him on the phone +420 776 750 591.

[vc_row][vc_column][insignia_section_heading title="Drop us a line" subtitle="We will respond as soon as possible, typically within 48 hours." align="text-center" c_margin_top="20" c_margin_bottom="20" add_icon="" font_weight="default" sub_font_weight="default"][contact-form-7 id="13965"][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space height="80px"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column width="1/1"][vc_column_text]

author foto
Krystof Sigut

OUR CASE STUDY

Scale-up to accelerate drug discovery

Our experience helped overcome development hurdles for potential cancer & mental health drugs.

Read more

Empowering neuro research with pro-N6pA

Sigut Labs scaled up pro-N6pA production, simplifying AMPylation research & boosting accessibility.

Read more

ADC development leaps with new linkers

Novel linker design expedited ADC advancement, leading to promising lead compounds faster.

Read more

Lincomycin derivative scale-up

Over 30 g of the desired product with exceptional purity was obtained through our optimized procedure.

Read more

Purifying 350 kg of vitamin K2 oil

Our innovative scale-up technology helped to reduce the client’s purification process from days to hours.

Read more

Our services

What we excel in so you don’t have to

View more
Thumbnail image Custom synthesis

Custom synthesis

Providing for a custom synthesis of previously reported molecules using described synthetic procedures.

Thumbnail image Contract research

Contract research

Developing novel synthetic routes to provide undescribed compounds in organic, bioorganic, and medicinal chemistry.

Thumbnail image Scale-Up

Scale-Up

Helping you go from lab scales to an industrial scale by applying our cutting-edge instrumentation.

Contact
Kryštof

Get in touch

Krystof Sigut, CEO and Founder
arrow

Our Experts

Profile image Krystof Sigut
Krystof Sigut
- CEO and Founder -
International chemical practitioner eager to restore Czech chemistry's global prestige. Contact Krystof for inquiries, NDA signing, or business matters.
Profile image Petr Slavik
Petr Slavik
- Head of Chemistry -
Synthetic chemistry pro with a decade's diverse lab expertise. For offers, research discussions, or detailed insights, reach out to Petr directly.

Partners & distributors

logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner